RD
RDED.F Relx PLC ADR
- Market cap
- EUR 61.1B
- P/E
- 24.4x
- P/B
- 40.81x
- ROE
- 87.3%
- Dividend yield
- 2.30%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is RDED.F undervalued?
Graham numberThe Graham number of Relx PLC ADR cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Relx PLC ADR fundamental analysis
No fundamental analysis for Relx PLC ADR yet.
Relx PLC ADR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Relx PLC ADR
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicti…
Full company profileRelx PLC ADR financial statements
Relx PLC ADR annual financial statements (GBP; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 6.90B | 7.36B | 7.49B | 7.87B | 7.11B | 7.24B | 8.55B | 9.16B | 9.43B | 9.59B |
| Gross Profit | 4.41B | 4.72B | 4.85B | 5.12B | 4.62B | 4.68B | 5.51B | 5.95B | 6.13B | 6.36B |
| Operating Income | 1.67B | 1.87B | 1.93B | 2.06B | 1.51B | 1.86B | 2.30B | 2.64B | 2.82B | 2.98B |
| EBITDA | - | 2.48B | 2.57B | 2.83B | 2.48B | 2.67B | 3.03B | 3.31B | 3.54B | 3.69B |
| Net Income | 1.16B | 1.66B | 1.42B | 1.51B | 1.22B | 1.47B | 1.63B | 1.78B | 1.93B | 2.07B |
| EPS | - | 0.82 | 0.72 | 0.78 | 0.63 | 0.76 | 0.86 | 0.95 | 1.04 | 1.14 |
| Balance Sheet | ||||||||||
| Total Assets | 13.3B | 12.3B | 14.0B | 13.8B | 14.1B | 13.9B | 15.8B | 14.9B | 15.1B | 14.8B |
| Total Liabilities | 11.0B | 9.91B | 11.6B | 11.6B | 12.0B | 10.6B | 12.1B | 11.5B | 11.6B | 12.4B |
| Shareholders' Equity | 2.32B | 2.35B | 2.33B | 2.17B | 2.10B | 3.23B | 3.78B | 3.46B | 3.48B | 2.37B |
| Cash & Short-term Investments | 162M | 111M | 114M | 138M | 88.0M | 113M | 334M | 155M | 119M | 131M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 1.74B | 1.91B | 1.99B | 2.09B | 1.60B | 2.02B | 2.40B | 2.46B | 2.61B | 2.84B |
| Capital Expenditure | 333M | 51.0M | 56.0M | 47.0M | 43.0M | 28.0M | 36.0M | 477M | 484M | 525M |
| Free Cash Flow | - | 1.49B | 1.62B | 1.71B | 1.23B | 1.68B | 1.97B | 1.98B | 2.12B | 2.31B |
| Ratios | ||||||||||
| ROE | 50.0% | 70.5% | 61.1% | 69.5% | 58.3% | 45.5% | 43.3% | 51.5% | 55.6% | 87.3% |
| ROA | 8.7% | 13.5% | 10.2% | 10.9% | 8.7% | 10.6% | 10.3% | 11.9% | 12.8% | 14.0% |
| Net Profit Margin | 16.8% | 22.6% | 19.0% | 19.1% | 17.2% | 20.3% | 19.1% | 19.4% | 20.5% | 21.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Relx PLC ADR dividends
- Dividend yield
- 2.30%
- Forward dividend
- 0.80 EUR
- Payout ratio
- 57.2%
- Ex-dividend date
- Aug 7, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | GBP 1.18B | 0.65 | 57.2% |
| 2024 | GBP 1.12B | 0.60 | 58.0% |
| 2023 | GBP 1.06B | 0.56 | 59.5% |
| 2022 | GBP 983M | 0.51 | 60.2% |
| 2021 | GBP 920M | 0.48 | 62.5% |
| 2020 | GBP 880M | 0.46 | 71.9% |
| 2019 | GBP 842M | 0.43 | 55.9% |
| 2018 | GBP 796M | 0.40 | 56.0% |
| 2017 | GBP 762M | 0.38 | 45.9% |
| 2016 | EUR 683M | - | 58.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 4:1 on Jul 1, 2015.
Who owns Relx PLC ADR
- Insiders 0.00%
- Institutions 5.23%
- Public & others 94.77%
- Shares outstanding 1.73B
- Free float 6.94B
Relx PLC ADR company profile
- Company name
- Relx PLC ADR
- Ticker
- RDED.F
- Exchange
- Frankfurt Exchange
- Sector
- Industrials
- Industry
- Commercial Services & Supplies
- Employees
- 37,000
- Fiscal year end
- December
- Address
- 1-3 Strand, London, United Kingdom, WC2N 5JR
- Phone
- 44 20 7166 5500
- Website
- relx.com
About Relx PLC ADR
RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Relx PLC ADR management
10- Mr. Erik Engstrom M.Sc Econ, M.Sc Eng., MBACEO & Executive Director · born 1963
- Mr. Nicholas Lawrence LuffCFO & Executive Director · born 1967
- Ms. Bianca Elisabeth Maria TetterooWorkforce Engagement Director & Independent Non-Executive Director · born 1969
- Mr. Paul Daniel Alexander SullivanHead of Investor Relations · born 1973
- Mr. Henry Adam Udow IV, J.D.Chief Legal Officer & Company Secretary · born 1957
- Mr. Paul AbrahamsHead of Corporate Communications
- Ms. Rosemary ThomsonChief Human Resources Officer · born 1969
- Dr. Marcia BaliscianoChief Sustainability Officer & Global Head of Corporate Responsibility
- Mr. Michael WalshChief Executive Officer of Legal & Risk
- Mr. Vijay RaghavanChief Technology Officer of Risk